ISSNHLIdiopathic Sudden Sensorineural Hearing Loss Syndrome
Copyright 1988-2018, All rights reserved.
References in periodicals archive ?
In our study, we compared the outcomes of the different treatment methods used in the patients followed-up for ISSNHL and aimed to identify the most successful modes of treatment based on the assessment of the prognostic factors, the audiogram types and the time from onset to treatment.
Presence of accompanying tinnitus and/or vertigo, systemic disorders, time from onset of hearing loss, otoscopic examination results and hearing status were recorded along with the demographic characteristics of the cases that were treated and followed-up for ISSNHL.
There is no definite treatment protocol available at present for ISSNHL, most accepted treatment modality being systemic steroids.
Comparison of Outcome based on Age of Incidence of ISSNHL
A previous investigation of the efficacy of steroidal therapy in diabetic patients with ISSNHL highlights the importance of close monitoring of blood sugar levels during treatment period and the need of more frequent use of insulin [6].
This increase in DM prevalence warrants careful assessment of treatment outcomes and close monitoring of any treatment-related complications of ISSNHL in diabetic patients.
In this study, we aimed to investigate the association of NLR and PLR with ISSNHL and to provide its usability of emerging as a cheap, reliable, and independent prognostic marker of ISSNHL, for the first time.
We reviewed 1046 consecutive ISSNHL patients treated in our department from 2009 to 2013 in our retrospective data analysis.
If left untreated, the ISSNHL and associated tinnitus will resolve partially or completely at least 50% of the time.
That includes ISSNHL, which you should suspect whenever a patient reports an unexplained decrease in hearing, as well as pulsatile tinnims, vestibular symptoms, and long-standing ear pain, drainage, or malodor that does not resolve with routine treatment.
The aim of this study was to evaluate the procalcitonin and hs-CRP levels in ISSNHL patients and assess their correlations with the clinical prognosis.